MIAPaCa-2  Xenografts

 

 

Rincon Bio performs MIAPaCa-2 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Pancreatic

MIAPaCa-2 cells were derived from 65 year old male Caucasian

Notes

Organism: Homo sapiens, human  /  Cell Type: epithelial cell  /  Tissue: pancreas  /  Disease: carcinoma

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics.  Tumors develop after being injected into the flank of immunocompromised mice. 

Request Quote

Receive a quote within one business day for a MIAPaCa-2 Xenograft

Rincon Bio Growth Curve

miapaca2.png

Cell Line: MIAPaCa-2 

Mouse Strain: Athymic Nude from Harlan Laboratories 

Gender: Female 

Positive Control: None 

Concentration: 1N/A 

Matrigel: Yes 

Cells Implanted per Animal: 5 million 

From implant to stratification: 8 days 

Stratification Size: 72mm^3 

Dosing: Vehicle - N/A

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are flexible and easy to work with.  And we take a personal interest in our clients' studies.